According to recent studies, enduring symptoms of Covid-19, a phenomenon known as ‘long Covid’, could impact about one in ten individuals who contract the virus during pregnancy. Expanded upon at the Society for Maternal-Fetal Medicine’s annual meeting, the study utilized data from the National Institutes of Health’s Recover Initiative. This project was initiated to decipher the long-term effects of Covid-19 in both adults and children. From the collected data of 1,503 pregnant individuals, approximately 9.3% reported experiencing enduring symptoms six months following their infection. Amongst the most frequently reported symptoms were fatigue and intermittent dizziness after minimal physical or mental exertion.
Interestingly, these figures are relatively lower compared to the rate of long Covid in the general American population; various contrasts in defining ‘long’ Covid could contribute to this disparity.
Dr. Torri Metz, a co-author of the study and an associate professor of obstetrics and gynecology at the University of Utah Health, offers an insightful hypothesis. She suggests the discrepancy may be attributed to fewer baseline medical complications in pregnant individuals and their younger age. Moreover, the unique immune responses observed during pregnancy could play a role.
Typically, the immune system of a pregnant individual becomes more tolerant to foreign bodies to support fetal growth. This tendency, however, often leaves them more susceptible to illnesses due to a restrained immune response. This factor could possibly lead to a reduced inflammation response to infection, which is often linked to prolonged inflammation and subsequent organ damage in long Covid cases.
Further findings revealed that certain demographics of pregnant individuals were more prone to developing long Covid, such as those with obesity, chronic anxiety or depression, or a need for supplemental oxygen during illness. Surprisingly, neither the gradation of pregnancy nor vaccination status played a statistically significant role in the likelihood of contracting long Covid.
As half of the individuals with long Covid had been fully vaccinated, this reinforces evidence that suggests vaccination reduces the risk of severe disease and the consequently higher likelihood of long Covid. Concerns remain over the socioeconomic factors influencing access to appropriate healthcare for long Covid, with a high proportion of affected individuals reportedly struggling with financial difficulties.
The second study delves into the prevalence of long Covid in children, suggesting up to 6 million have been affected. Most notably, a third of young patients displayed symptoms even a year after their initial infection, mainly breathing difficulties and fatigue. The studies are a reminder not to downplay the longer-term impacts of Covid-19 on younger populations. Intriguingly, the research also pointed towards an increased risk of autoimmune disorders, such as type 1 diabetes, post-infection, even in cases exhibiting mild or no symptoms.
These pioneering studies provide valuable insights but also underscore the need for further research, particularly into the outcomes for infants of those enduring long Covid and a more thorough understanding of the common factors shared by children suffering from long Covid.